BioCentury
ARTICLE | Clinical News

Idelvion albutrepenonacog alfa regulatory update

March 7, 2016 8:00 AM UTC

EMA’s CHMP recommended approval of Idelvion albutrepenonacog alfa from CSL for the treatment and prophylaxis of bleeding in patients with hemophilia B. Idelvion is approved in Canada and is also under...